Justin A Renz sold $29k of ARDX
Chief Financial Officer at ARDELYX, INC.. 5,171 shares at an average of $5.62, traded Feb 20, 2025, filed Feb 21, 2025.
Score components
- +22RoleCFO
- +5Trade size$29k at market
- 0Share of holdings soldSold 1.8% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-007232, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | SOpen-market sale Common Stock | -5,171 | $5.62 | $29k | 285,968 | Feb 21, 2025 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | ARDELYX, INC. | Joseph James Reilly See Remarks | $61k 11,086 shares | -9% | |
| 35Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $32k 5,814 shares | -2% | |
| 36Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $36k 6,426 shares | -2% | |
| 35Weak | ARDELYX, INC. | Mike Kelliher See Remarks | $31k 5,560 shares | -2% | |
| 53Moderate | ARDELYX, INC. | Michael Raab President & CEO | $260k 46,887 shares | -3% | |
| 36Weak | ARDELYX, INC. | Elizabeth A Grammer See Remarks | $33k 5,995 shares | -2% | |
| 35Weak | ARDELYX, INC. | Mike Kelliher Chief Business Officer | $32k 5,417 shares | -2% | |
| 18Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $490k 80,000 shares | -18% | |
| 39Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $91k 15,308 shares | -5% | |
| 36Weak | ARDELYX, INC. | Elizabeth A Grammer See Remarks | $35k 5,841 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.